Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/2011
06/15/2011EP1392833B1 Site-targeted transformation using amplification vectors
06/15/2011CN1942578B Low virulent strain of recombinant newcastle disease lasota vaccine expressing HA protein of avian influenza-H5 virus
06/15/2011CN102094035A Expression vector for constructing high-quality bacteriophage antibody library
06/15/2011CN102093983A Human diploid cell rabies vaccine virus seed and preparation method thereof
06/15/2011CN102093982A H9N2 subtype avian influenza virus strain and application thereof
06/15/2011CN101591658B ING4 and IL-24 dual gene co-expression vector and application thereof
06/15/2011CN101586120B Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector
06/15/2011CN101418286B Artificial pseudotype virus of human immunodeficiency virus I type as well as preparation and application thereof
06/15/2011CN101250503B In-vitro propagation method of tuberose virus
06/14/2011US7959930 Rescue of influenza virus
06/14/2011US7959929 isolated influenza virus that is capable of infecting a canid animal; genetic engineered influenza virus; vaccines for inducing an immune response against an influenza virus; veterinary medicine
06/14/2011US7959928 Viral like particle for use in for enhancing immune response and treating inflammatory and autoimmune disease
06/14/2011CA2399846C Gm-negative ehv-mutants
06/14/2011CA2309315C Adenovirus vectors and method for reducing homologous recombination phenomena
06/14/2011CA2301327C Use of herpes vectors for tumor therapy
06/14/2011CA2210732C Recombinant swinepox virus
06/10/2011CA2724942A1 Virally induced biofilm-like structure and uses thereof
06/09/2011WO2011068019A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein
06/09/2011WO2011067553A1 Cells for the production of biotin - tagged viral vectors or proteins
06/09/2011WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
06/09/2011US20110136689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells
06/09/2011US20110136688 Recombinant bacteriophage and methods for their use
06/09/2011US20110136227 Optimisation of expression of parvoviral rep and cap proteins in insect cells
06/09/2011US20110136210 Use of methylsulfonylmethane (msm) to modulate microbial activity
06/09/2011US20110136209 Process for the preparation of nicotine-based haptens
06/09/2011US20110136208 Antigen-specific regulatory t-cell induction
06/09/2011US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
06/09/2011US20110135686 Replication-Defective Flavivirus Vaccines and Vaccine Vectors
06/09/2011US20110135683 Modified vaccinia virus ankara for the vaccnation of neonates
06/09/2011US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof
06/09/2011US20110135676 Novel antiviral peptide against avian influenza virus h9n2
06/09/2011US20110135659 Fish Vaccine
06/08/2011EP2330189A1 Method for large scale production of virus
06/08/2011EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD)
06/08/2011EP1954811B1 Inducible expression systems
06/08/2011CN1784242B A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
06/08/2011CN102089430A Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
06/08/2011CN102086453A Tumor DNA vaccine taking mucin 1 and survivin as targets and viral vector vaccine
06/08/2011CN102086447A Duck virus hepatitis strains and inactivated vaccine
06/08/2011CN102086446A Strain of Adenoviridae and application thereof
06/08/2011CN101603035B Porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and method for producing living vaccine with same
06/08/2011CN101380470B Pig parvovirus live vaccine
06/08/2011CN101353667B HIV stain drug-resistant phenotype analytical cell model and special pseudotype lentivirus therefor
06/08/2011CN101353666B HIV medicament screening cell model and special pseudotype lentivirus therefor
06/07/2011US7955833 Derived from soy hydrolysate and yeast hydrolysate; useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal proteins
06/07/2011US7955600 Attenuated salmonella SP12 mutants as antigen carriers
06/03/2011WO2011064630A1 New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
06/03/2011WO2011014693A3 Bacteriophages expressing amyloid peptides and uses thereof
06/03/2011CA2782189A1 New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
06/02/2011US20110129868 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells
06/02/2011US20110129446 Clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
06/02/2011US20110129443 Macrocyclic serine protease inhibitors
06/01/2011EP2327764A1 New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer
06/01/2011EP2327420A2 Monoparaimmunity inducers based on attenuated rabbit myxoma viruses
06/01/2011EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses
06/01/2011EP2326712A1 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof
06/01/2011EP1517987B1 Cotton rat lung cells for virus culture
06/01/2011EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof
06/01/2011CN102083973A Novel mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease
06/01/2011CN102080102A Vector for expressing recombinant adenovirus containing hCAT (human catalase) gene and recombinant adenovirus thereof
06/01/2011CN102078607A Preparation and application of recombinant adenovirus vector bivalent living vaccine for herpes progenitalis
06/01/2011CN102078606A Respiratory syncytial virosome vaccine and preparation method thereof
06/01/2011CN101338302B Recombination herpes simplex virus for tumor gene therapy
06/01/2011CN101230334B Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof
05/2011
05/31/2011US7951576 Methods for preparing cells and viruses
05/31/2011US7951575 Isolated phages and their use in food or pet food products
05/31/2011US7951384 Virus-like particles as vaccines for paramyxovirus
05/31/2011US7951383 Attenuated parainfluenza virus (PIV) vaccines
05/31/2011US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery
05/31/2011US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders
05/31/2011CA2339324C Protein delivery system using human papillomavirus virus-like particles
05/31/2011CA2292922C Process for inactivating enveloped viruses in a viral preparation of non-enveloped viruses
05/31/2011CA2215328C Novel human cytomegalovirus dna sequences
05/26/2011WO2011061849A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection
05/26/2011WO2011061848A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection
05/26/2011WO2011039639A3 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7
05/26/2011WO2011020530A3 Method for isolating viruses
05/26/2011WO2011002522A3 Methods of making and using synthetic viruses
05/26/2011WO2010137036A3 Japanese encephalitis vaccine and method of manufacturing the same
05/26/2011US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
05/26/2011US20110124703 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes
05/26/2011US20110124086 Hepatitis C Virus Culture System
05/26/2011US20110124085 Unsymmetrical cyanine dimer compounds and their application
05/26/2011US20110123569 Vaccine directed against adenovirus serotype 14
05/26/2011US20110123567 Recombinant rift valley fever (rvf) viruses and methods of use
05/26/2011US20110123560 Infectious Bursal Disease Virus Antigenic Isolates And Vaccines
05/26/2011US20110123559 Swine influenza hemagglutinin variants
05/26/2011US20110123496 Bismacrocyclic compounds as hepatitis c virus inhibitors
05/26/2011CA2781099A1 Improved bacterial membrane protein secrection
05/26/2011CA2781019A1 Display of disulfide linked dimeric proteins on filamentous phage
05/25/2011EP2325299A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors
05/25/2011EP2325298A2 Simian adenoviruses SAdV-36, -42.1, -42.2, AND -44 and uses thereof
05/25/2011EP2324113A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
05/25/2011EP2324112A1 Mutant pestivirus with mutations in core gene and ns3 region
05/25/2011EP2137301B1 Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment.
05/25/2011CN102076356A Attenuated pestivirus
05/25/2011CN102071219A Improved AAV2 (Adeno-Associated Virus II) vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome)
05/25/2011CN102071218A Peste des petits ruminants virus (PPRV) reverse genetic operating system and application thereof
05/25/2011CN101643721B Broad-spectrum safe anti influenza A virus vaccine for animals
05/25/2011CN101497876B Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 267